Maybe you missed this. I almost wish I had. Who wrote about how the Affordable Care Act is socialism in the Wall Street Journal this week? The blonde from Three’s Company, or if you want a more recent accomplishment, the writer who recommends alternative medicine instead of chemotherapy for treating cancer.
A helpful commenter on the WSJ post shared this list of this her books:
- Sexy Forever: How to Fight Fat after Forty
- The Sexy Forever Recipe Bible
- Stay Young & Sexy with Bio-Identical Hormone Replacement: The Science Explained
- Bombshell: Explosive Medical Secrets That Will Redefine Aging
- Anti-Aging Cures: Life Changing Secrets to Reverse the Effects of Aging
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Yep, Suzanne Somers has shifted from her normal topic of tips for retirees and has explained the evils of Obamacare for us. She has family members in Canada and their experiences are a clear sign of what’s to come in America:
My sister-in-law had to wait two months to get a General Practitioner. During this period she spent her days in bed vomiting continuously, unable to get any food or drink down because she couldn’t get an appointment with the doctor.
My 75-year-old Canadian girlfriend was denied treatment because she was too old. She died recently, having been given palliative care. That’s all the system would allow.
The real tragedy is that there are so many recent events that a WSJ columnist could use to craft a very valid critique of the ACA. What about all those cancelled policies? What about the fact that CMS can’t learn to run a complex web site in a month? What about the financial hit to payers if not enough people sign up? What about the shortage of primary care doctors?
Even if this “Experts” section is meant to bring in a wider array of voices to complement the paper’s paid reporters, anyone could come up with a better critique than this one.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Of course, I am rewarding their cheap trick by writing about this “expert.” Maybe fellow expert Morgan Fairchild will weigh in on the ACA next week and give me another reason to avoid the WSJ’s experts at all costs.
